The same drugs at higher concentrations trigger mitochondrial ROS production by the direct targeting of a mitochondrial potassium channel that is overexpressed in cancer cells, and induce apoptosis selectively in cancer cells, even in vivo, in melanoma and pancreatic ductal adenocarcinoma models [154]. The gene discussed is CCDC51; the disease is melanoma.